May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Injection Quantity Decreases With Delivery Delay in an in vitro Model of Intravitreal Triamcinolone Acetonide Injection
Author Affiliations & Notes
  • C.A. Lemley
    Ophthalmology, University Washington, Seattle, WA
  • D.A. Saperstein
    Ophthalmology, University Washington, Seattle, WA
  • Footnotes
    Commercial Relationships  C.A. Lemley, None; D.A. Saperstein, None.
  • Footnotes
    Support  Research to Prevent Blindness, Private Support from Jim and Jane Lea
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1456. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.A. Lemley, D.A. Saperstein; Injection Quantity Decreases With Delivery Delay in an in vitro Model of Intravitreal Triamcinolone Acetonide Injection . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1456.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the effect of needle gauge size and injection delay after sample preparation on triamcinolone acetonide intravitreal injection. Design: In–vitro experimental model. Methods: Multiple 0.1 cc samples of triamcinolone acetonide (Kenolog–40, 40 mg/ml; Bristol–Myer Squibb, Princeton, NJ) were prepared by standard methods for intravitreal injection in 1cc tuberculin syringes. Samples were injected into test tubes through 27 and 30 gauge needles both immediately after preparation and after 5 minutes of sitting horizontally on a bench top. Total injection quantities were determined by spectrophotometer at 240nm wavelength using absorbance concentration curve with standard methodology. The difference between groups was determined with the unpaired student–t test. Results: Final triamcinolone acetonide mean doses were 4.7 mg (range 4.2–4.9 mg) and 4.3 mg (range 3.9–4.7mg) through 27 and 30 gauge needles respectively when injected immediately after sample preparation. Mean dose quantities dropped to 2.8 mg (range 2.3–3.5) and 2.5 mg (range 1.8–3.2 mg) with 27 and 30 gauge needles when sample injections were delayed for 5 minutes. This differences were significant with both 27 gauge (p<0.0001) and 30 gauge needles (p<0.0001) respectively. This represents drug dose loss of 40% and 43% after 5 minutes of delay with 27 and 30 gauge needles. There was no statistically significant difference between the 30 gauge needles and the 27 gauge needles at either the immediate time point or at 5 minutes, p = 0.0544 and p = 0.1917, respectively. Conclusions: Previous studies have shown variation of intraocular triamcinolone acetonide concentrations after intravitreal injection. In this study, we hypothesize that inadvertent variation in injection quantities may be involved. With an in–vitro model, we demonstrate approximate 40% decrease in injection drug quantities after 5 minutes of delay compared to immediate injection with both 27 and 30 gauge needles. This is likely due to sedimentation of the drug during delay and filtering effect of the needle hub. We did not see a difference between 27 gauge and 30 gauge needles. This study reinforces the importance of prompt injection of triamcinolone acetonide after sample preparation.

Keywords: corticosteroids • vitreous • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×